This study aimed to evaluate the diagnostic performance of current fibrosis assessment methods and develop a novel, simplified scoring system—the Aspartate Aminotransferase (AST)-Thrombocytopenia-Albumin (ATA) score—to enhance ease of use and clinical applicability. Here, ATM is linked to Thrombocytopenia.